**Core Concept:** Beta-blockers are a class of medications that bind to beta-receptors, thereby decreasing the effects of catecholamines and reducing myocardial oxygen demand. They are commonly used in the management of various cardiovascular conditions, including congestive heart failure (CHF).

**Why the Correct Answer is Right:** In the context of starting beta-blocker therapy in a patient with congestive heart failure, Option D is the correct answer because it does not reflect the rationale for using beta-blockers in this setting. Beta-blockers are beneficial in CHF because they:

1. **Decrease myocardial oxygen demand:** Beta-blockers inhibit the effects of catecholamines, reducing the heart's sensitivity to these stress hormones. This leads to a decrease in cardiac workload and oxygen consumption, ultimately reducing the risk of heart failure progression.
2. **Improve diastolic function:** Beta-blockers can improve diastolic filling of the heart by reducing the afterload (blood pressure) and preload (cardiac filling pressure).
3. **Prevent atrial fibrillation and arrhythmias:** Beta-blockers can reduce the risk of atrial fibrillation and other arrhythmias, thereby decreasing the strain on the heart and improving overall cardiovascular health.

**Why Each Wrong Option is Incorrect:**

A. This option is incorrect because beta-blockers can improve cardiac output and reduce the workload on the heart, making them a viable treatment option for CHF patients.
B. Beta-blockers may initially worsen heart failure symptoms due to a temporary reduction in cardiac output and increased heart rate. However, this effect is temporary, and long-term benefits outweigh the initial worsening of symptoms.
C. Beta-blockers can decrease the risk of sudden cardiac death and improve overall cardiovascular health in CHF patients, making it incorrect to state that "It increases the risk of sudden cardiac death."

**Clinical Pearl:** Beta-blockers should be initiated cautiously in CHF patients, especially during the initial stages, and the dose should be titrated gradually to minimize adverse effects and ensure patient tolerance.